Home LiteratureArticle Details
PMID: 10777545 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation.

The Journal of biological chemistry ·Vol. 275 ·No. 17 ·2000-04-28 ·Pages 12560-4

Fuchs SY, Tappin I, Ronai Z

Abstract

Trans-activation of the activating transcription factor-2 (ATF2) in response to cellular stress requires the N-terminal phosphorylation of ATF2 by stress-activated protein kinases (SAPK). In this study, we investigated the role of ATF2 phosphorylation in the maintenance of ATF2 stability. Activation of SAPK by forced expression of DeltaMEKK1 increased overall ATF2 ubiquitination, presumably because of the enhanced dimerization of ATF2. Treatment of DeltaMEKK1-expressing cells with okadaic acid led to the increase in N-terminal phosphorylation, protection from ubiquitination, and accumulation of exogenously expressed ATF2, indicating the role of protein phosphatases in balancing the effects of stress kinases. Analysis of ubiquitination and degradation of the constitutively dimerized ATF2 mutant (ATF2(Delta150-248)) showed that activation of JNK or p38 kinase renders ATF2 resistant to ubiquitination and degradation. This effect is mediated by JNK/p38-dependent phosphorylation of ATF2 at Thr-69 and Thr-71, because the phosphorylation-deficient mutant (ATF2(Delta150-248-T69A,T71A)) was not protected from ubiquitination and degradation by the activation of SAPK. Treatment of cells with okadaic acid elevated the tumor necrosis factor alpha-induced ATF2 level and the extent of its specific N-terminal phosphorylation. Cycloheximide, which activates SAPK, while inhibiting protein synthesis, stabilized endogenous ATF2. However, treatment of cells with the high dose of SB203580, which inhibits JNK and p38 kinase, resulted in efficient degradation of ATF2 in cells exposed to cycloheximide. This degradation was abrogated by co-treatment with the proteasome inhibitor MG132. Our findings suggest that N-terminal phosphorylation of ATF2 dimers protect ATF2 from ubiquitination and degradation. We propose the hypothesis that the balance between SAPK and protein phosphatases affects the duration and magnitude of ATF2 transcriptional output because of the effect on substrate recognition for ubiquitination and degradation.

MeSH Terms
Activating Transcription Factor 2 Calcium-Calmodulin-Dependent Protein Kinases/physiology Cell Line Cyclic AMP Response Element-Binding Protein/metabolism Fibroblasts/metabolism Humans MAP Kinase Kinase Kinase 1 MAP Kinase Signaling System Models, Biological Okadaic Acid/pharmacology Phosphorylation Plasmids Protein Serine-Threonine Kinases/metabolism Time Factors Trans-Activators/metabolism Transcription Factors/metabolism Transfection Tumor Necrosis Factor-alpha/metabolism Ubiquitins/metabolism
Chemicals
ATF2 protein, human Activating Transcription Factor 2 Cyclic AMP Response Element-Binding Protein Trans-Activators Transcription Factors Tumor Necrosis Factor-alpha Ubiquitins Okadaic Acid Protein Serine-Threonine Kinases Calcium-Calmodulin-Dependent Protein Kinases MAP Kinase Kinase Kinase 1 MAP3K1 protein, human
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Fuchs S Y
Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.
Tappin I
Ronai Z
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2000-04-28
Pages
12560-4
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NCI NIH HHS · CA59908 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]